Brief: Lantheus Holdings Q4 Adjusted EPS USD 1.67 Vs. IBES Estimate USD 1.17
26/02/2026 12:00
Feb 26 (Reuters) - Lantheus Holdings Q4 revenue USD 406.8 million vs. IBES estimate USD 367.8 million. Q4 EPS USD 0.82 outlook FY revenue USD 1,400-1,450 million outlook FY adjusted EPS USD 5-5.25
Recent news on Lantheus Holdings
See all newsStreet View: Lantheus' tumor kit setback seen as temporary, with growth catalysts still ahead
Brief: Lantheus Receives Complete Response Letter From FDA For Lnth-2501 (Ga 68 Edotreotide)
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues (updated)
US FDA declines to approve Lantheus’ tumor imaging kit
$7 billion could be a 'light' price tag for Lantheus, Truist analysts say